Source: International Congress 2017 – COPD biomarkers
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
E. Jusufovic (Tuzla, Bosnia and Herzegovina). Peripheral Blood Eosinophils as Marker of Sputum Eosinophilia and Outocome of COPD Exacerbation. 3606

Member's Comments

No comment yet.

Related content which might interest you: Blood Eosinophils Correlate With Severe Exacerbations in Frequent Exacerbator Phenotype of COPD Source: International Congress 2018 – Biomarkers of COPD Year: 2018 Mechanisms of FeNO Non-Suppression in Severe Asthma: Analysis of Sputum Type 2 Cytokines and Chemokines Source: Virtual Congress 2020 – Phenotypes of asthma and COPD Year: 2020 Blood Eosinophils and Outcomes in Severe Hospitalized Exacerbations of COPD. Source: International Congress 2017 – COPD biomarkers Year: 2017 Diagnosing Pulmonary Tuberculosis by Pooling Induced Sputum Source: International Congress 2017 – Microbiology and laboratory techniques to monitor NTM infections Year: 2017 Community-Acquired Pneumonia with Evolving Cavitation and Peripheral Eosinophilia Source: International Congress 2018 – CC8 Non-resolving pneumonia Year: 2018 Predictors of sputum and BAL eosinophilia in the Wessex Severe Asthma Cohort Source: International Congress 2017 – Monitoring asthma control Year: 2017 Microbiome Characteristics of Induced Sputum compared to Bronchial Fluid and Upper Airway Samples Source: International Congress 2018 – Paediatric respiratory infections: translational and clinical perspectives Year: 2018 LATE-BREAKING ABSTRACT: Blood Eosinophil Count as a Biomarker of ICS Effectiveness in Reducing Exacerbation Rates in COPD Source: International Congress 2014 – Latest insights in airway diseases Year: 2014 Relation of sputum and BAL neutrophils to the development of Chronic Lung Allograft Dysfunction after lung transplantation Source: International Congress 2017 – The ongoing struggle: insights into chronic lung allograft dysfunction (CLAD) Year: 2017 Distribution of Blood Eosinophils Among Patients with COPD in Primary Care Source: International Congress 2017 – Management of asthma in different situations Year: 2017 Ozone and Sensitization Alter Airway and Nerve-associated Eosinophils Source: International Congress 2017 – Animal models of asthma and allergies Year: 2017 Peripheral blood eosinophilia and clinical phenotype in Bronchiectasis Source: International Congress 2018 – Improving the quality of life of patients with bronchiectasis Year: 2018 Distinct Tryptase and CPA3-positive Basophil Phenotypes in Healthy Individuals, Asthma, and COPD Source: International Congress 2017 – New immune markers for asthma and COPD Year: 2017 Late Breaking Abstract -  Bacterial Load and Inflammation in Sputum from patients with Alpha-1-Antitrypsin Deficiency as compared with COPD Patients Source: International Congress 2017 – Novel mechanisms and treatments for COPD Year: 2017 Induced sputum Source: Annual Congress 2009 - PG8 Asthma: monitoring airway disease Year: 2009 Induced sputum Source: Annual Congress 2003 - PG18 - Markers of inflammation in obstructive airway disease Year: 2003 Relationship between Neutrophilic Airway Inflammation and Airway Colonisation in non-Cystic Fibrosis Bronchiectasis Source: International Congress 2018 – Predicting the future: biomarkers of respiratory infection Year: 2018 LATE-BREAKING ABSTRACT: Is Blood Eosinophil Count a Predictor of Response to Bronchodilators in COPD? Source: International Congress 2014 – Latest insights in airway diseases Year: 2014 Sputum neutrophil differential cell count in health and relationship to disease severity in asthma Source: International Congress 2014 – Phenotyping and monitoring asthma and COPD Year: 2014 Induced sputum and bronchial hyperresponsiveness in COPD patients Source: International Congress 2014 – Airway biomarkers Year: 2014